Grail (NASDAQ:GRAL) Hits New 12-Month High – Here’s What Happened

Grail, Inc. (NASDAQ:GRAL) reached a new 52-week high during trading on Thursday . The stock traded as high as $39.48 and last traded at $39.26, with a volume of 1777607 shares traded. The stock had previously closed at $33.15.

Analyst Upgrades and Downgrades

GRAL has been the topic of several recent analyst reports. Wolfe Research initiated coverage on shares of Grail in a research note on Friday, November 15th. They issued a “peer perform” rating on the stock. Morgan Stanley assumed coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price for the company.

Grail Price Performance

The business has a 50 day simple moving average of $23.27 and a two-hundred day simple moving average of $17.82.

Grail (NASDAQ:GRAL) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The company had revenue of $28.65 million for the quarter. As a group, sell-side analysts expect that Grail, Inc. will post -65.16 EPS for the current year.

Insider Transactions at Grail

In other news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the transaction, the chief financial officer now owns 268,277 shares in the company, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in GRAL. Douglas Lane & Associates LLC bought a new position in shares of Grail during the fourth quarter valued at approximately $3,034,000. A. D. Beadell Investment Counsel Inc. purchased a new position in shares of Grail in the 4th quarter valued at $430,000. FNY Investment Advisers LLC bought a new position in shares of Grail in the 4th quarter worth $26,000. 180 Wealth Advisors LLC purchased a new stake in shares of Grail during the 4th quarter worth $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management purchased a new stake in shares of Grail during the 4th quarter worth $387,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.